Category: snoring and apnea

AASM Instills Kannan Ramar as President 0

AASM Instills Kannan Ramar as President

Kannan Ramar, MBBS, MD, became the 35th president of the American Academy of Sleep Medicine (AASM) board of directors. Ramar assumed the role during the virtual AASM annual membership meeting. He will serve a one-year term as president of the AASM.

Ramar will lead an organization with a combined membership of 11,000 individual members and accredited member sleep centers. Individual members of the AASM community include physicians, scientists, and other health care professionals who provide care for patients who have sleep disorders such as obstructive sleep apnea and chronic insomnia.

“During my term as president, the AASM will continue implementing our strategic plan, which we introduced to our members in January,” Ramar says in a release. “We are focused on raising awareness that sleep is essential to health, advocating to improve patient care, expanding the sleep team workforce, and positively influencing technology innovation to improve patient access to high quality, safe, and efficient sleep care.”

A member of the AASM since 2006, Ramar is a sleep medicine physician at the Center for Sleep Medicine and a professor of medicine in …

Positive Airway Pressure Devices Market to Reach $2.2 Billion During COVID-19 Pandemic 0

Positive Airway Pressure Devices Market to Reach $2.2 Billion During COVID-19 Pandemic

Following reports that COVID-19 led to severe shortages of respiratory ventilators globally, the demand of positive airway pressure devices is rising. Prior to the COVID-19 pandemic, the global positive airway pressure devices market was valued at US$1.8 billion in 2019, at a robust annual rate of 7.5%. The market growth is set to reach US$2.2 billion in 2020, says GlobalData, a data and analytics company.

Tina Deng, MSc, senior medical devices analyst at GlobalData, says in a release, “During ventilator shortage crisis, alternative devices capable of delivering breaths or pressure support have been considered to satisfy medically necessary treatment. In the US, FDA has issued Emergency Use Authorizations for ventilators, allowing use alternative products such positive pressure breathing devices during the COVID-19 pandemic.“

Continuous positive airway pressure (CPAP) machines are used to treat patients with sleep apnea who require short-term mechanical assistance. With increasing demand and a supply shortage of ventilators, many hospitals use CPAP machines as alternatives for ventilators.

Devices makers ResMed and Philips both reported strong Q1 results in the sector. Philips’ sleep and respiratory care sales grew …

In Canada, Doctor Bikes to Raise Sleep Apnea Awareness 0

In Canada, Doctor Bikes to Raise Sleep Apnea Awareness

Dave Merrell, founder of the Sleep Apnea Society of Canada, began his trip in Calgary on July 1 and is riding to Winnipeg, reports CTV News.

“We’re trying to deal with the COVID situation of course and all these things,” said Merrell. “If we can now start to suggest to individuals with sleep apnea that they have to be even more careful, then that’s an important message we should try to get out”

from Sleep Review…

Intranasal Leptin Prevents Opioid-Induced Sleep Apnea in Obese Mice 0

Intranasal Leptin Prevents Opioid-Induced Sleep Apnea in Obese Mice

In 2018, researchers at Johns Hopkins Medicine showed that delivering the hunger-suppressing hormone leptin into the nose could ease breathing problems in sleeping obese mice. In addition to its role in metabolism, leptin stimulates breathing and combats obstructive sleep apnea. Apnea is more common in people who are obese.

In a new study published in the July 1, 2020, issue of the American Journal of Respiratory Cell and Molecular Biology, the researchers report that the same nasal delivery method for leptin also can stimulate respiration in obese mice that stop breathing when on morphine.

When on opioids, people with sleep apnea are likely to have more breathing pauses than those who are not medicated. This can lead to overdose and potentially, death. If someone who has sleep apnea is admitted to a hospital for trauma, the patient may be given high doses of opioids to relieve pain. This puts them at increased risk of an overdose and its complications. If this happens and the patient stops breathing, physicians can administer naloxone to negate the opioids and trigger the …

Home Sleep Tests May Fill a Gap in Care for Stroke Patients, Study Finds 0

Home Sleep Tests May Fill a Gap in Care for Stroke Patients, Study Finds

The parts of the brain that modulate breathing during sleep can become damaged by a stroke. New research sheds light on how sleep testing can better reach stroke patients.

By Lisa Spear

Once a person has experienced a stroke, they have a much higher chance of having sleep-disordered breathing. This is likely due to brain damage, especially from strokes that occur in the back of the brain, in the brainstem, which regulates breathing and nerve function to the airways.

“Strokes in the back of the brain can actually weaken the airway and make the airway more susceptible to collapse,” says Mark Boulos, MD, MSc, University of Toronto assistant professor and staff neurologist at Stony Brook Health Sciences Centre.

Despite a high risk of obstructive sleep apnea (OSA), not all stroke patients are able to receive the gold standard in sleep diagnostic testing, in-lab polysomnography (PSG), for reasons that stem from the cost of the test to wanting to avoid the discomfort of an overnight stay in a sleep lab.

Many patients might find the in-lab test so inconvenient that they …

What’s Next for Sleep Disorders Centers? 0

What’s Next for Sleep Disorders Centers?

Even as the United States reopens, it’s not just exposure to COVID-19 that sleep professionals need to worry about. With sharp increases in unemployment and many facilities seeing drops in revenue, the road ahead for sleep labs is likely to look different than what has been traveled before.

By Yoona Ha

To learn about how the landscape of sleep medicine might change, Sleep Review interviewed a dozen business owners and clinicians on what the new normal in sleep will feel like. What trends are here to stay? How will infection control practices grow and develop? Who’s left out of treatment? Which innovations will stick around post-pandemic?

Sure, the pandemic may be unprecedented, but there are patterns in how the sleep industry is responding that gives us hints to what to look out for when the virus subsides.

A Future of Digitally-Enabled Care

Even long-time advocates of telemedicine didn’t foresee that the explosion of sleep medicine practice over the Internet would happen so suddenly.

“Part of me feels like people have been almost forced into adapting telemedicine before they were ready, …

ATS Shares Guidance on Restoring Elective Sleep Services 0

ATS Shares Guidance on Restoring Elective Sleep Services

An American Thoracic Society (ATS)-led international task force has released a guidance document to help guide clinicians on restoring elective in-person pulmonary and sleep services as COVID-19 incidence decreases in their communities. The new guidance, published online in the Annals of the American Thoracic Society, is titled “Restoring Pulmonary and Sleep Services as the COVID-19 Pandemic Lessens.”

The task force, comprised of clinicians who are members of the Association of Pulmonary, Critical Care, and Sleep Division Directors and/or the American Thoracic Society who are actively engaged in COVID-19 patient care, developed a consensus approach on how and when to restart services that were put on hold due to the Centers for Disease Control and Prevention (CDC) March 2020 recommendations to cancel elective services. Specific guidance is provided regarding elective services in outpatient pulmonary and sleep medicine clinics, pulmonary function testing laboratories, bronchoscopy and procedural suites, polysomnography laboratories, and pulmonary rehabilitation facilities.

[RELATED: Is Sleep Medicine “Essential”?]

“This document provides important guidance to health care institutions about when it is reasonable to begin resuming elective in-person clinical services in …

COVID-19 Is Causing a Resurgence of Sleep and Pain Disorders 0

COVID-19 Is Causing a Resurgence of Sleep and Pain Disorders

Pandemic-related stress has meant more patients need help with temporomandibular joint disorders at one dental sleep medicine center.

By Richard E. Klein, DDS

In the April 2020 issue of Sleep Review, Sree Roy wrote, “One of the best analogies I’ve seen described sleep as a ‘shield’ against stress.” She quoted a University of Queensland professor who said, “When you don’t get enough sleep the shield cracks and you are more susceptible to stress.”

That certainly is evident in today’s patients. The unexpected, volatile, and life-changing COVID-19 pandemic has caused multiple problems, including ramifications and causality of a variety of medical problems that had been controlled or under the radar previously. In my dental sleep medicine practice, I have seen this in relation to obstructive sleep apnea (OSA) and temporomandibular disorder (TMD).

OSA and TMD are two diagnoses that are intimately related to cranial anatomy. Multiple peer-reviewed articles indicate that a person with a retrognathic mandible is significantly more prone to both OSA and TMD. Adherent CPAP use that eliminates sleep-disordered breathing will not necessarily eliminate or reduce sleep

Startup Raises $8.25 Million in Series A-2 Funding for Minimally Invasive Treatment for Obstructive Sleep Apnea 0

Startup Raises $8.25 Million in Series A-2 Funding for Minimally Invasive Treatment for Obstructive Sleep Apnea

Minnesota medical device startup Cryosa completed its Series A-2 funding, raising $8.25 million to further develop its therapies for obstructive sleep apnea (OSA).

The round was led by life sciences firm, Santé Ventures, and HOYA Corporation, with additional institutional and individual investors. This latest funding round will be used to engage in first-in-human clinical trials. The company has completed pre-clinical testing, evaluating safety, and efficacy.

“Current surgical treatments for obstructive sleep apnea are invasive and do not focus on curing the root cause of the disorder,” says Cryosa founder Donald Gonzales, MD, in a release. “Cryosa was founded to develop minimally invasive, permanent therapies for OSA.”

James Eadie, MD, partner at Santé Ventures and Cryosa board member, says in a release, “There is a large, unmet medical need for a minimally invasive obstructive sleep apnea therapy. Cryosa’s approach is elegant and backed by a strong team of medical device entrepreneurs and engineers.”

“The market for OSA therapies is substantial and continues to grow,” says Rubal Bedi, global head and vice president of corporate venture capital at HOYA, in a release. …

Texas’ Dell Children’s Opens New Sleep Lab 0

Texas’ Dell Children’s Opens New Sleep Lab

Austin, Texas-based Dell Children’s Medical Center recently opened a newly expanded sleep lab dedicated for diagnoses, treatment, and prevention of pediatric sleep disorders. The 2,885 sq-ft sleep lab at Dell Children’s includes a designated sleep study center with six beds for overnight sleep evaluation and multiple sleep latency testing.

Dell Children’s sleep specialists can evaluate pediatric patients with any concerns related to sleep such as sleep apnea, insomnia, narcolepsy, sleepwalking, and other sleep disorders. The Dell Children’s Sleep Lab will be an open lab allowing physicians at other sites of care to order sleep studies for their patients, providing greater access to care for all pediatric patients in Central Texas and beyond.

“Poor sleep habits can have a negative impact on a child’s health,” says J. Brian Kang, MD, pulmonologist and medical director of Dell Children’s Sleep Lab, in a release. “The risks of inadequate sleep extends beyond tiredness; sleep disorders can cause serious medical issues and can lead to poor academic and behavior problems in children.”

The accredited sleep center includes separate clinics specializing in insomnia, CPAP, and sleep …